Trials / Conditions / Locally Advanced Unresectable Pancreatic Adenocarcinoma
Locally Advanced Unresectable Pancreatic Adenocarcinoma
5 registered clinical trials studyying Locally Advanced Unresectable Pancreatic Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma NCT05919238 | Impact Biotech Ltd | Phase 1 |
| Completed | Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer NCT05078775 | Faeth Therapeutics | N/A |
| Active Not Recruiting | Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable NCT04106856 | University of Utah | Phase 1 |
| Completed | Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer NCT03910387 | Emory University | Phase 2 |
| Completed | STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma NCT04098432 | University Hospital Hradec Kralove | Phase 1 / Phase 2 |